Pharmatech Asia Group
Pharmatech Asia Group, a leading name in the pharmaceutical and biotechnology sectors, is headquartered in Singapore, with significant operations across Southeast Asia. Founded in 2005, the company has established itself as a key player in the development and distribution of innovative healthcare solutions. Specialising in high-quality nutritional products and advanced pharmaceutical formulations, Pharmatech Asia Group is recognised for its commitment to research and development, ensuring that its offerings meet the evolving needs of the market. The company’s unique approach combines cutting-edge technology with rigorous quality control, setting it apart from competitors. With a strong market position and a reputation for excellence, Pharmatech Asia Group continues to achieve notable milestones, contributing to the advancement of health and wellness across the region.
DitchCarbon Score
How does Pharmatech Asia Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmatech Asia Group's score of 15 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmatech Asia Group's reported carbon emissions
Pharmatech Asia Group currently does not have available carbon emissions data for recent years, as no specific figures have been provided. However, the company is committed to addressing climate change through various initiatives. While there are no documented reduction targets or specific climate pledges outlined, Pharmatech Asia Group is likely to be aligning its practices with industry standards to mitigate its environmental impact. The absence of detailed emissions data suggests a potential area for improvement in transparency and accountability regarding their carbon footprint. As the pharmaceutical industry increasingly focuses on sustainability, Pharmatech Asia Group's future commitments and actions will be crucial in contributing to broader climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmatech Asia Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
